U.S. Health and Human Services Secretary Alex Azar announces ‘historic’ COVID-19 vaccine deal with Pfizer…
Azar, by the way, was a top executive at the pharmaceutical giant Eli Lilly (if he’d worked for Pfizer, we’d be very suspicious. Instead, we’re just normal-suspicious).
U.S. taxpayers will pay Pfizer $1.95 billion to make and deliver 100 million doses of its COVID-19 vaccine from the BNT162 vaccine program if it receives approval from the FDA. Unless there’s some unexpected internal bickering, we’re guessing it will be approved.